|

Tebentafusp-Tebn Clinical Trials

2 actively recruiting trials across 1 location

Also known as: IMCgp100, KIMMTRAK®, gp100 peptide-HLA-directed CD3 T cell engager, kimmtrak

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Thomas Jefferson University2

Indications

  • Cancer2
  • Liver Disease1
  • Locally Advanced Unresectable Uveal Melanoma1
  • Metastatic Uveal Melanoma1
  • Liver Cancer1

Philadelphia, Pennsylvania2 trials

Neoadjuvant Tebentafusp for Uveal Melanoma

Sidney Kimmel Cancer Center at Thomas Jefferson University

Phase 2
Tebentafusp-tebn With LDT in Metastatic UM

Thomas Jefferson University

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.